Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2005

View Archived Issues

Parthenolide, a potent and selective anti-leukemia agent

New data on cardiovascular drugs presented at the ASCPT

An endogenous cannabinoid prevents prostate cancer cell invasion

Lansoprazole prevents type 14 rhinovirus infection

Long-acting insulin analog Albulin effective in diabetic mice

Lipid extract from palm fruit effective in testosterone-induced prostatic hypertrophy in rats

NBI-56418 shows promise in the treatment of endometriosis

Preliminary phase I data on the efficacy of TA-NIC in nicotine addiction

AZD-0865 prevents gastric acid secretion following single and repeated dosing

R-483 does not interact with drugs metabolized by cytochrome P450 isoenzymes

Ferring signs infertility agreement with Metris Therapeutics for vorozole

Phase IIb study for Biobypass

Millenia Hope to sponsor new malaria study

BioFocus in drug target agreement with Lilly

Crestor labeling revision approved by FDA

MM-039 studied in phase II trial for rheumatoid arthritis

Corixa and Lorantis to develop therapeutic hepatitis B vaccine

Sinovac's avian influenza vaccine in preclinical development

Chiron Fluvirin vaccine license reinstated by U.K.MHRA

Dynport Vaccine launches VIGIV to treat complications of smallpox vaccination

Thyrogen receives new European approval

Prous Institute Launches the Epistemic Drug Discovery Project

Novel combinations of anticancer agents reported by Angiogene researchers

Novel dopamine/noradrenaline/serotonin reuptake inhibitors imparted by NeuroSearch

Merck scientists present new dipeptidyl peptidase IV inhibitors for type 2 diabetes

New TGF-beta receptor type I kinase inhibitors claimed by Millennium Pharmaceuticals

Japan Tobacco scientists announce the synthesis of new HLGPa inhibitors for diabetes

Icatibant reported at the ASCPT meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...